Treatment satisfaction in patients receiving dupilumab for moderate-to-severe atopic dermatitis

被引：0
|
作者：
Lans, A. [1 ]
Van der Schaft, J. [1 ]
Bakker, D. [1 ]
Ariens, L. [1 ]
Thijs, J. H. [1 ]
De Bruin-Weller, M. S. [1 ]
Balak, D. M. W. [1 ]
机构：
[1] Univ Med Ctr Utrecht, Utrecht, Netherlands
来源：
ALLERGY | 2019年 / 74卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
OA0141
引用
收藏
页码：82 / 82
页数：1
相关论文
共 50 条
  • [31] Rapid response to dupilumab treatment in children with moderate-to-severe atopic dermatitis: A case series
    Votto, Martina
    Delle Cave, Francesco
    De Filippo, Maria
    Marseglia, Alessia
    Marseglia, Gian Luigi
    Brazzelli, Valeria
    Licari, Amelia
    PEDIATRIC ALLERGY AND IMMUNOLOGY, 2022, 33 : 31 - 33
  • [32] Impact of dupilumab treatment on seasonal disease severity in adults with moderate-to-severe atopic dermatitis
    Beck, Lisa A.
    Simpson, Eric L.
    Ramien, Michele
    Tang, Mark
    Joyce, Joel C.
    Praestgaard, Amy
    Rossi, Ana B.
    Clearfield, Drew
    Zhang, Annie
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 191
  • [33] Effects of dupilumab treatment on circulating memory T regulatory cells in patients with moderate-to-severe atopic dermatitis
    Allakhverdi, Z.
    Patel, H.
    Dupuy, F.
    Bouchard, C.
    Jack, C.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2024, 144 (08) : S9 - S9
  • [34] Switching from dupilumab to abrocitinib in patients with moderate-to-severe atopic dermatitis: an analysis of responders and nonresponders to dupilumab
    Silverberg, Jonathan, I
    Simpson, Eric L.
    Thyssen, Jacob P.
    Pink, Andrew E.
    Weidinger, Stephan
    Chan, Gary
    Lazariciu, Irina
    Clibborn, Claire
    Guler, Erman
    BRITISH JOURNAL OF DERMATOLOGY, 2023, 188
  • [35] Profile of dupilumab and its potential in the treatment of inadequately controlled moderate-to-severe atopic dermatitis
    Awosika, Olabola
    Kim, Lori
    Mazhar, Momina
    Rengifo-Pardo, Monica
    Ehrlich, Alison
    CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY, 2018, 11 : 41 - 49
  • [36] Dupilumab treatment in moderate-to-severe atopic dermatitis: A systematic review and meta-analysis
    Wang, Fa-Ping
    Tang, Xiao-Ju
    Wei, Chuan-Qi
    Xu, Lin-Rui
    Mao, Hui
    Luo, Feng-Ming
    JOURNAL OF DERMATOLOGICAL SCIENCE, 2018, 90 (02) : 190 - 198
  • [37] An Observational Study of Early Treatment Response and Predictors of Dupilumab in the Treatment of Moderate-to-Severe Atopic Dermatitis
    Deng, Sisi
    Wang, Huan
    Fu, Jiong
    Zhai, Zhifang
    Chen, Qiquan
    Song, Zhiqiang
    DERMATOLOGIC THERAPY, 2024, 2024
  • [38] Biomarkers in tear fluid of dupilumab-treated moderate-to-severe atopic dermatitis patients
    Achten, Roselie
    Thijs, Judith
    van Luijk, Chantal
    Knol, Edward
    Delemarre, Eveline
    de Graaf, Marlies
    Bakker, Daphne
    de Boer, Joke
    van Wijk, Femke
    de Bruin-Weller, Marjolein
    CLINICAL AND EXPERIMENTAL ALLERGY, 2023, 53 (02): : 239 - 243
  • [39] Dupilumab Improves Skin Lipid Barrier in Pediatric Patients With Moderate-to-Severe Atopic Dermatitis
    Bronova, Irina
    Berdyshev, Evgeny
    Goleva, Elena
    Danby, Simon
    Bronoff, Anna Sofia
    Richers, Brittany
    Garcia, Shannon
    Gama, Marco Ramirez
    Taylor, Patricia
    Zahn, Joseph
    Agueusop, Inoncent
    Bafna, Shantanu
    Boguniewicz, Mark
    Ong, Peck
    Zhang, Annie
    Cork, Michael
    Leung, Donald
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2024, 153 (02) : AB5 - AB5
  • [40] Baricitinib for the treatment of pediatric patients with moderate-to-severe atopic dermatitis
    Paller, Amy
    Chu, Chia-Yu
    Yang, Chin-Yi
    Janes, Jonathan
    Prakash, Apurva
    Rueda, Maria Jose
    Stanley, Sarah
    Wu, Wen-Shuo
    Zhang, Xin
    Eichenfield, Lawrence
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB108 - AB108
12345